Beyond the conventional emphasis on amyloid Aβ and tau abnormalities, scientists are actively pinpointing new therapeutic targets for this illness. These include modulating brain inflammation through inhibiting immune cell activation, modifying neuronal impairment – particularly associated with excitatory neurotransmitter transmission – and in